FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21678111000001100: Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jan 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71727301000001115 Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
71727401000001111 Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Is a Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free true Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Has active ingredient Sodium alginate true Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Has active ingredient Potassium bicarbonate true Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Has manufactured dose form Oral dose form true Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Has specific active ingredient Sodium alginate true Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Has specific active ingredient Potassium bicarbonate true Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Has dispensed dose form Conventional release chewable tablet true Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Has excipient Aspartame false Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Flavour Mint true Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Is a Gaviscon Advance true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) 12 tablet 2 x 6 tablets Has AMP True Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) 24 tablet 4 x 6 tablets Has AMP True Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Inferred relationship Existential restriction modifier
Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) 60 tablet Has AMP True Gaviscon Advance Mint chewable tablets (Reckitt Benckiser Healthcare (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start